speb/financial-data huggingface dataset:
OBI.L cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 64000.00
OBI.L cash_flow (annual, 2025-12-31) — Change In Payable: 4804000.00
OBI.L cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -84000.00
OBI.L cash_flow (annual, 2025-12-31) — Change In Receivables: 49000.00
OBI.L cash_flow (annual, 2025-12-31) — Change In Working Capital: 3797000.00
OBI.L cash_flow (annual, 2025-12-31) — Changes In Cash: 254000.00
OBI.L balance_sheet (annual, 2025-12-31) — Common Stock: 288194000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Common Stock: 288194000.00
OBI.L balance_sheet (annual, 2025-12-31) — Common Stock Equity: 3485000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3485000.00
OBI.L cash_flow (annual, 2025-12-31) — Common Stock Issuance: 25981000.00
OBI.L income_statement (annual, 2025-12-31) — Cost Of Revenue: 1034000.00
OBI.L balance_sheet (annual, 2025-12-31) — Current Assets: 13263000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Current Assets: 13263000.00
OBI.L balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 312000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 312000.00
OBI.L balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 312000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 312000.00
OBI.L balance_sheet (annual, 2025-12-31) — Current Liabilities: 10795000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 10795000.00
OBI.L cash_flow (annual, 2025-12-31) — Depreciation: 590000.00
OBI.L cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 590000.00
OBI.L income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 522000.00
OBI.L income_statement (annual, 2025-12-31) — Depreciation Income Statement: 522000.00
OBI.L income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -29517000.00
OBI.L income_statement (annual, 2025-12-31) — EBIT: -29496000.00
OBI.L income_statement (annual, 2025-12-31) — EBITDA: -28906000.00
OBI.L cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 386000.00
OBI.L cash_flow (annual, 2025-12-31) — End Cash Position: 10566000.00
OBI.L cash_flow (annual, 2025-12-31) — Financing Cash Flow: 24218000.00
OBI.L balance_sheet (annual, 2025-12-31) — Finished Goods: 788000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Finished Goods: 788000.00
OBI.L cash_flow (annual, 2025-12-31) — Free Cash Flow: -23964000.00
OBI.L cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -64000.00
OBI.L income_statement (annual, 2025-12-31) — General And Administrative Expense: 8713000.00
OBI.L balance_sheet (annual, 2025-12-31) — Gross PPE: 2520000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2520000.00
OBI.L income_statement (annual, 2025-12-31) — Gross Profit: 1612000.00
OBI.L income_statement (annual, 2025-12-31) — Interest Expense: 21000.00
OBI.L income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 21000.00
OBI.L income_statement (annual, 2025-12-31) — Interest Income: 366000.00
OBI.L income_statement (annual, 2025-12-31) — Interest Income Non Operating: 366000.00
OBI.L cash_flow (annual, 2025-12-31) — Interest Paid Cff: 0.00
OBI.L balance_sheet (annual, 2025-12-31) — Inventory: 1821000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Inventory: 1821000.00
OBI.L balance_sheet (annual, 2025-12-31) — Invested Capital: 3485000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Invested Capital: 3485000.00
OBI.L cash_flow (annual, 2025-12-31) — Investing Cash Flow: -117000.00
OBI.L cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 25981000.00
OBI.L cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
OBI.L balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 101000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 101000.00
OBI.L balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 101000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 101000.00
OBI.L cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
OBI.L cash_flow (annual, 2025-12-31) — Long Term Debt Payments: 0.00
OBI.L balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 483000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 483000.00
OBI.L cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 25981000.00
OBI.L cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -478000.00
OBI.L income_statement (annual, 2025-12-31) — Net Income: -29517000.00
OBI.L income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -29517000.00
OBI.L income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -29517000.00
OBI.L income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -29517000.00
OBI.L income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -29517000.00
OBI.L cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -29517000.00
OBI.L income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -29517000.00
OBI.L income_statement (annual, 2025-12-31) — Net Interest Income: 345000.00
OBI.L cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
OBI.L cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
OBI.L income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 345000.00
OBI.L balance_sheet (annual, 2025-12-31) — Net PPE: 1065000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Net PPE: 1065000.00
OBI.L cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -117000.00
OBI.L balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 3485000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 3485000.00
OBI.L income_statement (annual, 2025-12-31) — Normalized EBITDA: -28970000.00
OBI.L income_statement (annual, 2025-12-31) — Normalized Income: -29581000.00
OBI.L cash_flow (annual, 2025-12-31) — Operating Cash Flow: -23847000.00
OBI.L income_statement (annual, 2025-12-31) — Operating Income: -29967000.00
OBI.L income_statement (annual, 2025-12-31) — Operating Revenue: 2646000.00
OBI.L balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 518366964.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 518366964.00
OBI.L balance_sheet (annual, 2025-12-31) — Other Current Assets: 5000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 5000.00
OBI.L balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 138000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 138000.00
OBI.L cash_flow (annual, 2025-12-31) — Other Non Cash Items: 744000.00
OBI.L balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 53000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 53000.00
OBI.L balance_sheet (annual, 2025-12-31) — Other Payable: 2045000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Other Payable: 2045000.00
OBI.L balance_sheet (annual, 2025-12-31) — Other Properties: 1742000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Other Properties: 1742000.00
OBI.L balance_sheet (annual, 2025-12-31) — Other Receivables: 49000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Other Receivables: 49000.00
OBI.L income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
OBI.L balance_sheet (annual, 2025-12-31) — Payables: 3081000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Payables: 3081000.00
OBI.L balance_sheet (annual, 2025-12-31) — Prepaid Assets: 411000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 411000.00
OBI.L income_statement (annual, 2025-12-31) — Pretax Income: -29517000.00
OBI.L balance_sheet (annual, 2025-12-31) — Properties: 0.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
OBI.L cash_flow (annual, 2025-12-31) — Purchase Of PPE: -117000.00
OBI.L balance_sheet (annual, 2025-12-31) — Raw Materials: 809000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Raw Materials: 809000.00
OBI.L income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1034000.00
OBI.L income_statement (annual, 2025-12-31) — Reconciled Depreciation: 590000.00
OBI.L cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
OBI.L income_statement (annual, 2025-12-31) — Research And Development: 21229000.00
OBI.L balance_sheet (annual, 2025-12-31) — Restricted Cash: 0.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 0.00
OBI.L balance_sheet (annual, 2025-12-31) — Retained Earnings: -314949000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -314949000.00
OBI.L income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 1115000.00
OBI.L income_statement (annual, 2025-12-31) — Selling General And Administration: 9828000.00
OBI.L balance_sheet (annual, 2025-12-31) — Share Issued: 518366964.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Share Issued: 518366964.00
OBI.L cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1081000.00
OBI.L balance_sheet (annual, 2025-12-31) — Stockholders Equity: 3485000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3485000.00
OBI.L balance_sheet (annual, 2025-12-31) — Tangible Book Value: 3485000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 3485000.00
OBI.L income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
OBI.L income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
OBI.L balance_sheet (annual, 2025-12-31) — Total Assets: 14381000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Total Assets: 14381000.00
OBI.L balance_sheet (annual, 2025-12-31) — Total Capitalization: 3485000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3485000.00
OBI.L balance_sheet (annual, 2025-12-31) — Total Debt: 413000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Total Debt: 413000.00
OBI.L balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 3485000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 3485000.00
OBI.L income_statement (annual, 2025-12-31) — Total Expenses: 32613000.00
OBI.L balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 10896000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 10896000.00
OBI.L balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1118000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1118000.00
OBI.L balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 101000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 101000.00
OBI.L income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -29967000.00
OBI.L income_statement (annual, 2025-12-31) — Total Unusual Items: 64000.00
OBI.L income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 64000.00
OBI.L balance_sheet (annual, 2025-12-31) — Work In Process: 224000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Work In Process: 224000.00
OBI.L balance_sheet (annual, 2025-12-31) — Working Capital: 2468000.00
OBI.L balance_sheet (quarterly, 2025-12-31) — Working Capital: 2468000.00
OBIO income_statement (annual, 2021-12-31) — Basic Average Shares: 31614079.00
OBIO income_statement (annual, 2021-12-31) — Basic EPS: -0.73
OBIO cash_flow (annual, 2021-12-31) — Change In Account Payable: 1078000.00
OBIO cash_flow (annual, 2021-12-31) — Change In Payable: 1078000.00
OBIO balance_sheet (annual, 2021-12-31) — Construction In Progress: 16000.00
OBIO balance_sheet (annual, 2021-12-31) — Current Debt: 2000000.00
OBIO income_statement (annual, 2021-12-31) — Diluted Average Shares: 31614079.00
OBIO income_statement (annual, 2021-12-31) — Diluted EPS: -0.73
OBIO cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -699000.00
OBIO income_statement (annual, 2021-12-31) — Interest Expense: 927000.00
OBIO income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 927000.00
OBIO balance_sheet (annual, 2021-12-31) — Long Term Debt: 3673000.00
OBIO cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -4000000.00
OBIO balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 690000.00
OBIO cash_flow (annual, 2021-12-31) — Operating Gains Losses: -699000.00
OBIO balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 2000000.00
OBIO balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 635000.00
OBIO balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 535000.00
OBIO balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 51452000.00
OBIO balance_sheet (annual, 2021-12-31) — Prepaid Assets: 234000.00
OBIO cash_flow (annual, 2021-12-31) — Repayment Of Debt: -4000000.00
OBIO balance_sheet (annual, 2021-12-31) — Total Tax Payable: 1000.00
OBIO income_statement (annual, 2022-12-31) — +Operating Expense: 35979000.00
OBIO income_statement (annual, 2022-12-31) — +Total Revenue: 3533000.00
OBIO balance_sheet (annual, 2022-12-31) — Accounts Payable: 3968000.00
OBIO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 96000.00
OBIO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -778000.00
OBIO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 252274000.00
OBIO income_statement (annual, 2022-12-31) — Basic Average Shares: 31614079.00
OBIO income_statement (annual, 2022-12-31) — Basic EPS: -1.06
OBIO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 9938000.00
OBIO cash_flow (annual, 2022-12-31) — Capital Expenditure: -591000.00
OBIO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 2380000.00
OBIO balance_sheet (annual, 2022-12-31) — Capital Stock: 2000.00
OBIO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 19784000.00
OBIO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 83785000.00
OBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 103257000.00
OBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -64122000.00
OBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -29289000.00
OBIO cash_flow (annual, 2022-12-31) — Change In Inventory: -208000.00
OBIO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -319000.00
OBIO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -2862000.00
OBIO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 3352000.00
OBIO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -439000.00
OBIO cash_flow (annual, 2022-12-31) — Change In Receivables: 25000.00
OBIO cash_flow (annual, 2022-12-31) — Change In Working Capital: -451000.00
OBIO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 25000.00
OBIO cash_flow (annual, 2022-12-31) — Changes In Cash: 9846000.00
OBIO balance_sheet (annual, 2022-12-31) — Common Stock: 2000.00
OBIO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 52534000.00
OBIO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 109830000.00
OBIO income_statement (annual, 2022-12-31) — Cost Of Revenue: 211000.00
OBIO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 2896000.00
OBIO balance_sheet (annual, 2022-12-31) — Current Assets: 84690000.00
OBIO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 697000.00
OBIO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 697000.00
OBIO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 6436000.00
OBIO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 6436000.00
OBIO balance_sheet (annual, 2022-12-31) — Current Liabilities: 18566000.00
OBIO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 222000.00
OBIO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 222000.00
OBIO income_statement (annual, 2022-12-31) — Diluted Average Shares: 31614079.00
OBIO income_statement (annual, 2022-12-31) — Diluted EPS: -1.06
OBIO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -33608000.00
OBIO income_statement (annual, 2022-12-31) — EBIT: -32657000.00
OBIO income_statement (annual, 2022-12-31) — EBITDA: -32435000.00
OBIO cash_flow (annual, 2022-12-31) — End Cash Position: 19784000.00
OBIO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 103257000.00
OBIO cash_flow (annual, 2022-12-31) — Free Cash Flow: -29880000.00
OBIO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 1350000.00
OBIO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -319000.00
OBIO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -8000.00
OBIO balance_sheet (annual, 2022-12-31) — Gross PPE: 4454000.00
OBIO income_statement (annual, 2022-12-31) — Gross Profit: 3322000.00
OBIO income_statement (annual, 2022-12-31) — Interest Income: 50000.00
OBIO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 50000.00
OBIO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 1371000.00
OBIO balance_sheet (annual, 2022-12-31) — Inventory: 276000.00
OBIO balance_sheet (annual, 2022-12-31) — Invested Capital: 62024000.00
OBIO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -64122000.00
OBIO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 2495000.00
OBIO balance_sheet (annual, 2022-12-31) — Investments And Advances: 2495000.00
OBIO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 109830000.00
OBIO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 10000000.00
OBIO balance_sheet (annual, 2022-12-31) — Leases: 191000.00
OBIO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1683000.00
OBIO balance_sheet (annual, 2022-12-31) — Long Term Debt: 9490000.00
OBIO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 11173000.00
OBIO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 10000000.00
OBIO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -6446000.00
OBIO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 364000.00
OBIO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 109830000.00
OBIO income_statement (annual, 2022-12-31) — Net Income: -33608000.00
OBIO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -33608000.00
OBIO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -33608000.00
OBIO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -33608000.00
OBIO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -33608000.00
OBIO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -33608000.00
OBIO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -33608000.00
OBIO income_statement (annual, 2022-12-31) — Net Interest Income: 50000.00
OBIO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -63531000.00
OBIO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 3554000.00
OBIO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 3554000.00
OBIO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 50000.00
OBIO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -10317000.00
OBIO balance_sheet (annual, 2022-12-31) — Net PPE: 3676000.00
OBIO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -591000.00
OBIO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 52534000.00
OBIO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 13103000.00
OBIO balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 13103000.00
OBIO income_statement (annual, 2022-12-31) — Normalized EBITDA: -31434000.00
OBIO income_statement (annual, 2022-12-31) — Normalized Income: -32607000.00
OBIO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -29289000.00
OBIO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 2032000.00
OBIO income_statement (annual, 2022-12-31) — Operating Income: -32657000.00
OBIO income_statement (annual, 2022-12-31) — Operating Revenue: 3533000.00
OBIO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 31614079.00
OBIO balance_sheet (annual, 2022-12-31) — Other Current Assets: 533000.00
OBIO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 2089000.00
OBIO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -8000.00
OBIO income_statement (annual, 2022-12-31) — Other Income Expense: -1001000.00
OBIO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 134000.00
OBIO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 4711000.00
OBIO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 196000.00
OBIO balance_sheet (annual, 2022-12-31) — Other Properties: 3899000.00
OBIO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 64001000.00
OBIO income_statement (annual, 2022-12-31) — Other Special Charges: 682000.00
OBIO balance_sheet (annual, 2022-12-31) — Payables: 3968000.00
OBIO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 6864000.00
OBIO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2480000.00
OBIO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
OBIO income_statement (annual, 2022-12-31) — Pretax Income: -33608000.00
OBIO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 190000.00
OBIO balance_sheet (annual, 2022-12-31) — Properties: 0.00
OBIO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -63531000.00
OBIO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -591000.00
OBIO balance_sheet (annual, 2022-12-31) — Receivables: 96000.00
OBIO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 211000.00
OBIO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 222000.00
OBIO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -6446000.00
OBIO income_statement (annual, 2022-12-31) — Research And Development: 21945000.00
OBIO balance_sheet (annual, 2022-12-31) — Retained Earnings: -199734000.00
OBIO cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
OBIO income_statement (annual, 2022-12-31) — Selling General And Administration: 14034000.00
OBIO balance_sheet (annual, 2022-12-31) — Share Issued: 31614079.00
OBIO income_statement (annual, 2022-12-31) — Special Income Charges: -682000.00
OBIO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3413000.00
OBIO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 52534000.00
OBIO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 52534000.00
OBIO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
OBIO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
OBIO balance_sheet (annual, 2022-12-31) — Total Assets: 95572000.00
OBIO balance_sheet (annual, 2022-12-31) — Total Capitalization: 62024000.00
OBIO balance_sheet (annual, 2022-12-31) — Total Debt: 11870000.00
OBIO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 52534000.00
OBIO income_statement (annual, 2022-12-31) — Total Expenses: 36190000.00
OBIO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 43038000.00
OBIO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 10882000.00
OBIO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 24472000.00
OBIO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -32657000.00
OBIO income_statement (annual, 2022-12-31) — Total Unusual Items: -1001000.00
OBIO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1001000.00
OBIO balance_sheet (annual, 2022-12-31) — Trading Securities: 2495000.00
OBIO cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: -1031000.00
OBIO balance_sheet (annual, 2022-12-31) — Working Capital: 66124000.00
OBIO income_statement (annual, 2023-12-31) — +Operating Expense: 54080000.00
OBIO income_statement (annual, 2023-12-31) — +Total Revenue: 2760000.00
OBIO balance_sheet (annual, 2023-12-31) — Accounts Payable: 2900000.00
OBIO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 99000.00
OBIO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1044000.00
OBIO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 316903000.00
OBIO income_statement (annual, 2023-12-31) — Basic Average Shares: 33225227.00
OBIO income_statement (annual, 2023-12-31) — Basic EPS: -1.48
OBIO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 19784000.00
OBIO cash_flow (annual, 2023-12-31) — Capital Expenditure: -78000.00
OBIO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1687000.00
OBIO balance_sheet (annual, 2023-12-31) — Capital Stock: 4000.00
OBIO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 30559000.00
OBIO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 87595000.00
OBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 46215000.00
OBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 10687000.00
OBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -46127000.00
OBIO cash_flow (annual, 2023-12-31) — Change In Inventory: 131000.00
OBIO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -693000.00
OBIO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -2106000.00
OBIO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 145000.00
OBIO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -781000.00
OBIO cash_flow (annual, 2023-12-31) — Change In Receivables: -3000.00
OBIO cash_flow (annual, 2023-12-31) — Change In Working Capital: -3307000.00
OBIO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -3000.00
OBIO cash_flow (annual, 2023-12-31) — Changes In Cash: 10775000.00
OBIO balance_sheet (annual, 2023-12-31) — Common Stock: 4000.00
OBIO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 68043000.00
OBIO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
OBIO income_statement (annual, 2023-12-31) — Cost Of Revenue: 186000.00
OBIO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 2488000.00
OBIO balance_sheet (annual, 2023-12-31) — Current Assets: 89114000.00
OBIO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 649000.00
OBIO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 649000.00
OBIO balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 2510000.00
OBIO balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 2510000.00
OBIO balance_sheet (annual, 2023-12-31) — Current Liabilities: 11208000.00
OBIO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 287000.00
OBIO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 287000.00
OBIO income_statement (annual, 2023-12-31) — Diluted Average Shares: 33225227.00
OBIO income_statement (annual, 2023-12-31) — Diluted EPS: -1.48
OBIO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -49120000.00
OBIO income_statement (annual, 2023-12-31) — EBIT: -51506000.00
OBIO income_statement (annual, 2023-12-31) — EBITDA: -51219000.00
OBIO cash_flow (annual, 2023-12-31) — End Cash Position: 30559000.00
OBIO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 46215000.00
OBIO cash_flow (annual, 2023-12-31) — Free Cash Flow: -46205000.00
OBIO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 294000.00
OBIO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -312000.00
OBIO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -10000.00
OBIO balance_sheet (annual, 2023-12-31) — Gross PPE: 3878000.00
OBIO income_statement (annual, 2023-12-31) — Gross Profit: 2574000.00
OBIO income_statement (annual, 2023-12-31) — Interest Income: 3849000.00
OBIO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 3849000.00
OBIO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1119000.00
OBIO balance_sheet (annual, 2023-12-31) — Inventory: 146000.00
OBIO balance_sheet (annual, 2023-12-31) — Invested Capital: 68043000.00
OBIO cash_flow (annual, 2023-12-31) — Investing Cash Flow: 10687000.00
OBIO balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 2495000.00
OBIO balance_sheet (annual, 2023-12-31) — Investments And Advances: 2495000.00
OBIO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
OBIO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
OBIO balance_sheet (annual, 2023-12-31) — Leases: 203000.00
OBIO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1038000.00
OBIO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1038000.00
OBIO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
OBIO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -10849000.00
OBIO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 343000.00
OBIO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
OBIO income_statement (annual, 2023-12-31) — Net Income: -49120000.00
OBIO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -49120000.00
OBIO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -49120000.00
OBIO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -49120000.00
OBIO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -49120000.00
OBIO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -49120000.00
OBIO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -49120000.00
OBIO income_statement (annual, 2023-12-31) — Net Interest Income: 3849000.00
OBIO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 10765000.00
OBIO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -10849000.00
OBIO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -10849000.00
OBIO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 3849000.00
OBIO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 56810000.00
OBIO balance_sheet (annual, 2023-12-31) — Net PPE: 2834000.00
OBIO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -78000.00
OBIO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 68043000.00
OBIO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 14923000.00
OBIO balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 14923000.00
OBIO income_statement (annual, 2023-12-31) — Normalized EBITDA: -49756000.00
OBIO income_statement (annual, 2023-12-31) — Normalized Income: -47657000.00
OBIO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -46127000.00
OBIO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 1445000.00
OBIO income_statement (annual, 2023-12-31) — Operating Income: -51506000.00
OBIO income_statement (annual, 2023-12-31) — Operating Revenue: 2760000.00
OBIO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 35777412.00
OBIO balance_sheet (annual, 2023-12-31) — Other Current Assets: 1274000.00
OBIO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -10000.00
OBIO income_statement (annual, 2023-12-31) — Other Income Expense: -1463000.00
OBIO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -3075000.00
OBIO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 769000.00
OBIO balance_sheet (annual, 2023-12-31) — Other Properties: 3332000.00
OBIO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 57036000.00
OBIO income_statement (annual, 2023-12-31) — Other Special Charges: 1151000.00
OBIO balance_sheet (annual, 2023-12-31) — Payables: 2900000.00
OBIO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 5388000.00
OBIO balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2661000.00
OBIO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
OBIO income_statement (annual, 2023-12-31) — Pretax Income: -49120000.00
OBIO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 254000.00
OBIO balance_sheet (annual, 2023-12-31) — Properties: 0.00
OBIO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -142032000.00
OBIO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -78000.00
OBIO balance_sheet (annual, 2023-12-31) — Receivables: 99000.00
OBIO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 186000.00
OBIO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 287000.00
OBIO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -10849000.00
OBIO income_statement (annual, 2023-12-31) — Research And Development: 33822000.00
OBIO balance_sheet (annual, 2023-12-31) — Retained Earnings: -248854000.00
OBIO cash_flow (annual, 2023-12-31) — Sale Of Investment: 152797000.00
OBIO income_statement (annual, 2023-12-31) — Selling General And Administration: 20258000.00
OBIO balance_sheet (annual, 2023-12-31) — Share Issued: 35777412.00
OBIO income_statement (annual, 2023-12-31) — Special Income Charges: -1151000.00
OBIO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 7625000.00
OBIO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 68043000.00
OBIO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 68043000.00
OBIO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
OBIO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
OBIO balance_sheet (annual, 2023-12-31) — Total Assets: 95212000.00
OBIO balance_sheet (annual, 2023-12-31) — Total Capitalization: 68043000.00
OBIO balance_sheet (annual, 2023-12-31) — Total Debt: 1687000.00
OBIO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 68043000.00
OBIO income_statement (annual, 2023-12-31) — Total Expenses: 54266000.00
OBIO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 27169000.00
OBIO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 6098000.00
OBIO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 15961000.00
OBIO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -51506000.00
OBIO income_statement (annual, 2023-12-31) — Total Unusual Items: -1463000.00
OBIO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1463000.00
OBIO balance_sheet (annual, 2023-12-31) — Trading Securities: 2495000.00
OBIO cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 18000.00
OBIO balance_sheet (annual, 2023-12-31) — Working Capital: 77906000.00
OBIO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 37621495.00
OBIO income_statement (quarterly, 2024-09-30) — Basic EPS: -0.41
OBIO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 37621495.00
OBIO income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.41
OBIO income_statement (quarterly, 2024-09-30) — Interest Income: 916000.00
OBIO income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 916000.00
OBIO income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: -916000.00
OBIO income_statement (annual, 2024-12-31) — +Operating Expense: 66735000.00
OBIO income_statement (annual, 2024-12-31) — +Total Revenue: 2638000.00
OBIO balance_sheet (annual, 2024-12-31) — Accounts Payable: 5134000.00
OBIO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 92000.00
OBIO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1303000.00
OBIO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 342780000.00
OBIO income_statement (annual, 2024-12-31) — Basic Average Shares: 36821042.00
OBIO income_statement (annual, 2024-12-31) — Basic EPS: -1.66
OBIO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 30559000.00
OBIO cash_flow (annual, 2024-12-31) — Capital Expenditure: -289000.00
OBIO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 2237000.00
OBIO balance_sheet (annual, 2024-12-31) — Capital Stock: 4000.00
OBIO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 22261000.00
OBIO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 66812000.00
OBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 29171000.00
OBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 13089000.00
OBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -50558000.00
OBIO cash_flow (annual, 2024-12-31) — Change In Inventory: -28000.00
OBIO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -652000.00
OBIO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -2005000.00
OBIO cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: -77000.00
OBIO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 2969000.00
OBIO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -1071000.00
OBIO cash_flow (annual, 2024-12-31) — Change In Receivables: 22000.00
OBIO cash_flow (annual, 2024-12-31) — Change In Working Capital: -765000.00
OBIO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 22000.00
OBIO cash_flow (annual, 2024-12-31) — Changes In Cash: -8298000.00
OBIO balance_sheet (annual, 2024-12-31) — Common Stock: 4000.00
OBIO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 32958000.00
OBIO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 15035000.00
OBIO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
OBIO income_statement (annual, 2024-12-31) — Cost Of Revenue: 204000.00
OBIO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 3472000.00
OBIO balance_sheet (annual, 2024-12-31) — Current Assets: 69171000.00
OBIO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 550000.00
OBIO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 550000.00
OBIO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 4439000.00
OBIO balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 4439000.00
OBIO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 4439000.00
OBIO balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 4439000.00
OBIO balance_sheet (annual, 2024-12-31) — Current Liabilities: 16207000.00
OBIO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 308000.00
OBIO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 308000.00
OBIO balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
OBIO balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 0.00
OBIO income_statement (annual, 2024-12-31) — Diluted Average Shares: 36821042.00
OBIO income_statement (annual, 2024-12-31) — Diluted EPS: -1.66
OBIO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -61024000.00
OBIO income_statement (annual, 2024-12-31) — EBIT: -64301000.00
OBIO income_statement (annual, 2024-12-31) — EBITDA: -63993000.00
OBIO cash_flow (annual, 2024-12-31) — End Cash Position: 22261000.00
OBIO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 29171000.00
OBIO cash_flow (annual, 2024-12-31) — Free Cash Flow: -50847000.00
OBIO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -68000.00
OBIO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 0.00
OBIO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 52000.00
OBIO balance_sheet (annual, 2024-12-31) — Gross PPE: 4790000.00
OBIO income_statement (annual, 2024-12-31) — Gross Profit: 2434000.00
OBIO income_statement (annual, 2024-12-31) — Interest Income: 3356000.00
OBIO income_statement (quarterly, 2024-12-31) — Interest Income: 522000.00
OBIO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 3356000.00
OBIO income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 522000.00
OBIO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 102000.00
OBIO balance_sheet (annual, 2024-12-31) — Inventory: 173000.00
OBIO balance_sheet (annual, 2024-12-31) — Invested Capital: 47250000.00
OBIO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 13089000.00
OBIO balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 2495000.00
OBIO balance_sheet (annual, 2024-12-31) — Investments And Advances: 2495000.00
OBIO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 15035000.00
OBIO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
OBIO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 15000000.00
OBIO balance_sheet (annual, 2024-12-31) — Leases: 159000.00
OBIO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1687000.00
OBIO balance_sheet (annual, 2024-12-31) — Long Term Debt: 14292000.00
OBIO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 15979000.00
OBIO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 15000000.00
OBIO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
OBIO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 444000.00
OBIO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 15035000.00
OBIO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
OBIO income_statement (annual, 2024-12-31) — Net Income: -61024000.00
OBIO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -61024000.00
OBIO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -61024000.00
OBIO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -61024000.00
OBIO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -61024000.00
OBIO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -61024000.00
OBIO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -61024000.00
OBIO income_statement (annual, 2024-12-31) — Net Interest Income: 3356000.00
OBIO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 13980000.00
OBIO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 15000000.00
OBIO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 15000000.00
OBIO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 3356000.00
OBIO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1104000.00
OBIO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -602000.00
OBIO balance_sheet (annual, 2024-12-31) — Net PPE: 3487000.00
OBIO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -289000.00
OBIO cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
OBIO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 32958000.00
OBIO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 10989000.00
OBIO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 10989000.00
OBIO balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 10989000.00
OBIO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 10989000.00
OBIO income_statement (annual, 2024-12-31) — Normalized EBITDA: -63925000.00
OBIO income_statement (annual, 2024-12-31) — Normalized Income: -60956000.00
OBIO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -50558000.00
OBIO income_statement (annual, 2024-12-31) — Operating Income: -64301000.00
OBIO income_statement (annual, 2024-12-31) — Operating Revenue: 2638000.00
OBIO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 38194442.00
OBIO balance_sheet (annual, 2024-12-31) — Other Current Assets: 2094000.00
OBIO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 52000.00
OBIO income_statement (annual, 2024-12-31) — Other Income Expense: -79000.00
OBIO income_statement (quarterly, 2024-12-31) — Other Income Expense: 0.00
OBIO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 240000.00
OBIO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1020000.00
OBIO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 40000.00
OBIO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -11000.00
OBIO income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 0.00
OBIO balance_sheet (annual, 2024-12-31) — Other Properties: 4187000.00
OBIO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 44551000.00
OBIO balance_sheet (annual, 2024-12-31) — Payables: 5134000.00
OBIO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 8606000.00
OBIO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2612000.00
OBIO balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
OBIO balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
OBIO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
OBIO cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
OBIO income_statement (annual, 2024-12-31) — Pretax Income: -61024000.00
OBIO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 240000.00
OBIO balance_sheet (annual, 2024-12-31) — Properties: 0.00
OBIO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -72648000.00
OBIO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -289000.00
OBIO balance_sheet (annual, 2024-12-31) — Receivables: 92000.00
OBIO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 204000.00
OBIO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 308000.00
OBIO cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
OBIO income_statement (annual, 2024-12-31) — Research And Development: 42804000.00
OBIO balance_sheet (annual, 2024-12-31) — Retained Earnings: -309878000.00
OBIO cash_flow (annual, 2024-12-31) — Sale Of Investment: 86628000.00
OBIO income_statement (annual, 2024-12-31) — Selling General And Administration: 23931000.00
OBIO balance_sheet (annual, 2024-12-31) — Share Issued: 38194442.00
OBIO income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
OBIO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 10615000.00
OBIO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 32958000.00
OBIO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 32958000.00
OBIO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
OBIO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
OBIO balance_sheet (annual, 2024-12-31) — Total Assets: 76173000.00
OBIO balance_sheet (annual, 2024-12-31) — Total Capitalization: 47250000.00
OBIO balance_sheet (annual, 2024-12-31) — Total Debt: 16529000.00
OBIO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 32958000.00
OBIO income_statement (annual, 2024-12-31) — Total Expenses: 66939000.00
OBIO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 43215000.00
OBIO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 7002000.00
OBIO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 27008000.00
OBIO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -64301000.00
OBIO income_statement (annual, 2024-12-31) — Total Unusual Items: -68000.00
OBIO income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
OBIO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -68000.00
OBIO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
OBIO balance_sheet (annual, 2024-12-31) — Trading Securities: 2495000.00
OBIO cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 68000.00
OBIO cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
OBIO balance_sheet (annual, 2024-12-31) — Working Capital: 52964000.00